Submissions from 2025
Use of multiple micronutrient supplementation integrated into routine antenatal care: A discussion of research priorities, Tabassum Firoz, Jahnavi Daru, Jennifer Busch-Hallen, Özge Tunçalp, and Lisa M. Rogers
Fertility preserving, uterine sparing approach to a uterine extragonadal yolk sac tumor, Michelle Greenman, Blair McNamara, Victoria Ettorre, Natalia Buza, and Masoud Azodi
Predictive value of homocysteine levels in embryo culture media for embryo selection in infertile patients with endometriosis, Metehan İmamoğlu, Mahmut Öncül, Abdullah Tüten, and Levent M. Şentürk
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2, Levent Mutlu, Blair McNamara, Stefania Bellone, Diego D. Manavella, Cem Demirkiran, Michelle Greenman, Migues Skyler Z. Veroza, Natalia Buza, Pei Hui, Tobias Max Philipp Harwitch, Justin Harold, Margherita Zipponi, Gary Altwerger, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, M Azodi, Peter E. Schwartz, and Alessandro D. Santin
Repair of Microperforate Hymen, Lauren Roth, Anne K. Smith, Elisabeth Stark, and Alla Vash-Margita
The Multidisciplinary Management of a Patient With Infected Iliocaval Stents and Uterine Cancer Invasion, Shreef Said MD, Emily Gu, Andrew X. Li MD, Sarah Ann Loh MD, Hamid Mojibian, M Azodi, and Cassius Iyad Chaar
The Effect of Concomitant Hysterectomy Route on Robotic Sacrocolpopexy Outcomes, Christina Swallow, Metehan Imamoglu, Aysegul Gizem Imamoglu, Xiao Xu, and Oz Harmanli
Navigating Pregnancy Testing in Chronic Pain Management for Women of Reproductive Age, Shoran Tamura, Swarnima Vardhan, Kathryn Breidenbach, Naum Shaparin, Amaresh Vydyanathan, and Karina Gritsenko
Induction of labor outcomes: Insights from a single-center experience from Yemen, Anessa Thabet, Menawar Dajenah, Faisal Ahmed, Saif Ghabisha, Zaid Dajenah, Abdulghani Al-Hagri, and Mohamed A. Badheeb
Submissions from 2024
Assessing Recommendations for Determining Fetal Risk in Alloimmunized Pregnancies in the United States: Is It Time to Update a Decades-Old Practice?, Elizabeth Abels, Brian D. Adkins, Koraima Cedeno, Garrett S. Booth, Elizabeth S. Allen, Laura D. Stephens, Jennifer S. Woo, Christopher A. Tormey, and Jeremy W. Jacobs
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix, Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, Camilla Krakstad, Blair McNamara, Michelle Greenman, Levent Mutlu, Cem Demirkiran, Tobias Max Hartwich, Yang Yang-Hartwich, Margherita Zipponi, Natalia Buza, Pei Hui, Francesco Raspagliesi, Salvatore Lopez, Biagio Paolini, Massimo Milione, Emanuele Perrone, Giovanni Scambia, Gary Altwerger, Antonella Ravaggi, Eliana Bignotti, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E. Schwartz, Charles M. Quick, Roberto Angioli, Corrado Terranova, and Samir Zaidi
[Recommendations for clinical practice of the CNGOF on the prevention of Rhesus alloimmunisation in the 1st trimester: Is de-escalation really reasonable?], Jeremy Boujenah, Kenneth J. Moise, Claude d'Ercole, and Bruno Carbonne
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study, Kristen K. Curtis, Nathan J. Fakult, Jennifer L. Strunck, Sumaira Z. Aasi, Christine S. Ahn, Murad Alam, Anna A. Bar, Ramona Behshad, Christopher K. Bichakjian, Diana Bolotin, Susan L. Boone, Jeremy S. Bordeaux, Jerry D. Brewer, David R. Carr, John A. Carucci, Jason R. Castillo, Sean R. Christensen, Melanie A. Clark, Lindsey K. Collins, Addison M. Demer, Daniel B. Eisen, Hao Feng, Bahar F. Firoz, Roy C. Grekin, Jason M. Hirshburg, Todd E. Holmes, Conway C. Huang, Thomas A. Jennings, Shang I. Jiang, Sailesh Konda, Justin J. Leitenberger, and Jesse M. Lewin
Clinical Presentation and Outcomes of Diabetic Ketoacidosis in Pregnancy, Jennifer L. Grasch, Sydney Lammers, Florencia Scaglia Drusini, Selina S. Vickery, Kartik K. Venkatesh, Stephen Thung, Monique E. McKiever, Mark B. Landon, and Steven Gabbe
Addressing Racial Disparities in the Hypertensive Disorders in Pregnancy: A Plan for Action from the Preeclampsia Foundation's Racial Disparities Task Force, Cornelia R. Graves, Tabassum Firoz, Skylar N. Smith, Natalie Hernandez, Shaconna Haley, Kim Smith, Robyn D'Oria, and Ann C. Celi
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions, Jeremy W. Jacobs, Garrett S. Booth, Sheharyar Raza, Landon M. Clark, Ross M. Fasano, Eleni Gavriilaki, Elizabeth A. Abels, Thomas C. Binns, and Miriam Andrea Duque
Management of Red Cell Alloimmunization in Pregnancy, Kenneth J. Moise and Elizabeth A. Abels
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147), Sangini S. Sheth, Ji Eun Oh, Stefania Bellone, Eric R. Siegel, Michelle Greenman, Levent Mutlu, Blair McNamara, Shefali Pathy, Mitchell Clark, Masoud Azodi, Gary Altwerger, Vaagn Andikyan, Gloria Huang, Elena Ratner, Daniel J. Kim, Akiko Iwasaki, Angelique W. Levi, Natalia Buza, Pei Hui, Sean Flaherty, Peter E. Schwartz, and Alessandro D. Santin
Submissions from 2023
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer, Julia H. Gelissen, Naomi N. Adjei, Blair McNamara, Levent Mutlu, Justin A. Harold, Mitchell Clark, Gary Altwerger, Peter R. Dottino, Gloria S. Huang, Alessandro D. Santin, Masoud Azodi, Elena Ratner, Peter E. Schwartz, and Vaagn Andikyan
The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo, Chanhee Han, Blair McNamara, Stefania Bellone, Justin Harold, Paola Manara, Tobias Max Hartwich, Levent Mutlu, Yang Yang-Hartwich, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Verzosa, Gary Altwerger, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter R. Dottino, Peter E. Schwartz, and Alessandro D. Santin
Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma, Justin Harold, Stefania Bellone, Diego D. Manavella, Levent Mutlu, Blair McNamara, Tobias Max Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Verzosa, Jungmin Choi, Weilai Dong, Natalia Buza, Pei Hui, Gary Altwerger, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma", Justin Harold, Stefania Bellone, Diego D. Manavell, Levent Mutlu, Blair McNamara, Tobias Max Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Verzosa, Jungmin Choi, Weilai Dong, Natalia Buza, Pei Hui, Gary Altwerger, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor, Diego D. Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Hartwich, Yang Yang-Hartwich, Levent Mutlu, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Verzosa, Gary Altwerger, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, Peter R. Dottino, Jungmin Choi, Ludmil B. Alexandrov, Natalia Buza, Pei Hui, and Alessandro D. Santin
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression, Dennis Mauricio, Stefania Bellone, Levent Mutlu, Blair McNamara, Diego D. Manavella, Cem Demirkiran, Miguel Skyler Verzosa, Natalia Buza, Pei Hui, Tobias Max Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipponi, Gary Altwerger, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor, Blair McNamara, Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias Max Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Verzosa, Kevin Yang, Jungmin Choi, Weilai Dong, Natalia Buza, Pei Hui, Gary Altwerger, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E. Schwartz, Elizabeth A. Burton, Hiroaki Inagaki, Aaron Albers, Chao Zhang, Gideon Bollag, Joseph Schlessinger, and Alessandro D. Santin
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma, Levent Mutlu, Diego D. Manavella, Stefania Bellone, Blair McNamara, Justin A. Harold, Dennis Mauricio, Eric R. Siegel, Natalia Buza, Pei Hui, Tobias Max Hartwich, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Verzosa, Gary Altwerger, Elena S. Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter R. Dottino, Peter E. Schwartz, and Alessandro D. Santin
Submissions from 2022
Editorial: Maternal Health in Conflict Settings, Ribka Amsalu, Tabassum Firoz, Isabelle L. Lange, and Hannah Tappis
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability, Stefania Bellone, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jungsoo Lee, Dan-Arin Silasi, Gloria S. Huang, Vaagn Andikyan, Shari Damast, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Joan R. Tymon-Rosario, Justin A. Harold, Dennis Mauricio, Burak Zeybek, Gulden Menderes, Gary Altwerger, Elena Ratner, Ludmil B. Alexandrov, Akiko Iwasaki, Yong Kong, Eric Song, Weilai Dong, Julia A. Elvin, and Jungmin Choi
Non-communicable diseases and maternal health: a scoping review, Tabassum Firoz, Beth Pineles, Nishika Navrange, Alyssa Grimshaw, Olufemi Oladapo, and Doris Chou
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects, Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, Bobbie J. Rimel, Jørn Herrstedt, Amit M. Oza, Ulrich Canzler, Jonathan S. Berek, Antonio González-Martín, Phillipe Follana, Rosemary Lord, Masoud Azodi, Kasey Estenson, Zebin Wang, Yong Li, Divya Gupta, Ursula Matulonis, and Bin Feng
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor, Joan R. Tymon-Rosario, Paola Manara, Diego D. Manavella, Stefania Bellone, Tobias Max Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipponi, Jungmin Choi, Kyungjo Jeong, Levent Mutlu, Kevin Yang, Gary Altwerger, Gulden Menderes, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, Ludmil B. Alexandrov, and Alessandro D. Santin
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu, Ghanshyam Yadav, Dana M. Roque, Stefania Bellone, Diego D. Manavella, Tobias M. Hartwich, Margherita Zipponi, Justin Harold, Joan Tymon-Rosario, Levent Mutlu, Gary Altwerger, Gulden Menderes, Elena Ratner, Natalia Buza, Pei Hui, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Ludmil B. Alexandrov, and Alessandro D. Santin
Submissions from 2021
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793), S Bellone, D M. Roque, E R. Siegel, N Buza, P Hui, E Bonazzoli, A Guglielmi, L Zammataro, N Nagarkatti, S Zaidi, J Lee, D-A Silasi, G S. Huang, V Andikyan, S Damast, M Clark, M Azodi, P E. Schwartz, J Tymon-Rosario, J Harold, D Mauricio, B Zeybek, G Menderes, G Altwerger, E Ratner, L B. Alexandrov, A Iwasaki, Y Kong, E Song, W Dong, J Elvin, and J Choi
Integrated mutational landscape analysis of uterine leiomyosarcomas, Jungmin Choi, Aranzazu Manzano, Weilai Dong, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Xiaotong Yao, Aditya Deshpande, Samir Zaidi, Adele Guglielmi, Barbara Gnutti, Nupur Nagarkatti, Joan R. Tymon-Rosario, Justin Harold, Dennis Mauricio, Burak Zeybek, Gulden Menderes, Gary Altwerger, Kyungjo Jeong, Siming Zhao, Natalia Buza, Pei Hui, Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Paola Todeschini, Laura Zanotti, Franco Odicino, Sergio Pecorelli, Laura Ardighieri, Kaya Bilguvar, and Charles M. Quick
DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo, Joan Tymon-Rosario, Elena Bonazzoli, Stefania Bellone, Aranzazu Manzano, Silvia Pelligra, Adele Guglielmi, Barbara Gnutti, Nupur Nagarkatti, Burak Zeybek, Paola Manara, Luca Zammataro, Justin Harold, Dennis Mauricio, Natalia Buza, Pei Hui, Gary Altwerger, Gulden Menderes, Elena Ratner, Mitchell Clark, Vaagn Andikyan, Gloria S. Huang, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu, Joan Tymon-Rosario, Eric R. Siegel, Stefania Bellone, Justin Harold, Naomi Adjei, Burak Zeybek, Dennis Mauricio, Gary Altwerger, Gulden Menderes, Elena Ratner, Mitchell Clark, Vaagn Andikyan, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Amanda N. Fader, and Alessandro D. Santin
Financial toxicity in patients with gynecologic malignancies: a cross sectional study, Burak Zeybek, Emily Webster, Natalia Pogosian, Joan Tymon-Rosario, Alan Balch, Gary Altwerger, Mitchell Clark, Gulden Menderes, Gloria Huang, Masoud Azodi, Elena S. Ratner, Peter E. Schwartz, Alessandro D. Santin, and Vaagn Andikyan
Submissions from 2020
Laparoscopic Posterior Versus Lateral Transversus Abdominis Plane Block in Gynecology, Kelly Benabou, Soorin Kim, Christina H. Tierney, Joel E. Messom, Tassos C. Kyriakides, Shabnam M. Kashani, Dan-Arin Silasi, Masoud Azodi, and Farinaz Seifi
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma, Elena Bonazzoli, Stefania Bellone, Luca Zammataro, Barbara Gnutti, Adele Guglielmi, Silvia Pelligra, Nupur Nagarkatti, Paola Manara, Joan Tymon-Rosario, Burak Zeybek, Gary Altwerger, Gulden Menderes, Chanhee Han, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut, Katherine H. Campbell, Jean M. Tornatore, Kirsten E. Lawrence, Jessica L. Illuzzi, L Scott Sussman, Heather S. Lipkind, and Christian M. Pettker
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis, Amanda N. Fader, Dana M. Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M. O'Malley, Floor J. Backes, Nicole Nevadunsky, Babak Edraki, Dirk Pikaart, William Lowery, Karim ElSahwi, Paul Celano, Stefania Bellone, Masoud Azodi, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Peter E. Schwartz, and Alessandro D. Santin
In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma, Chanhee Han, Emanuele Perrone, Burak Zeybek, Stefania Bellone, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Jacqueline Feinberg, Kaitlin Haines, Mariana Espinal Muller Karger, Anna Bianchi, Luca Zammataro, Aranzazu Manzano, Elena Bonazzoli, Paola Manara, Natalia Buza, Pei Hui, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Salvatore Lopez, and Alessandro D. Santin
Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas, Salvatore Lopez, Emanuele Perrone, Stefania Bellone, Elena Bonazzoli, Burak Zeybek, Chanhee Han, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Anna Bianchi, Luca Zammataro, Aranzazu Manzano, Paola Manara, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Francesco Raspagliesi, Roberto Angioli, Natalia Buza, Pei Hui, Heather M. Bond, and Alessandro D. Santin
Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer, Emanuele Perrone, Salvatore Lopez, Burak Zeybek, Stefania Bellone, Elena Bonazzoli, Silvia Pelligra, Luca Zammataro, Aranzazu Manzano, Paola Manara, Anna Bianchi, Natalia Buza, Joan Tymon-Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, and Alessandro D. Santin
Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo, Emanuele Perrone, Paola Manara, Salvatore Lopez, Stefania Bellone, Elena Bonazzoli, Aranzazu Manzano, Luca Zammataro, Anna Bianchi, Burak Zeybek, Natalia Buza, Joan Tymon-Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Gloria S. Huang, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, and Alessandro D. Santin
Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study, Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, and Gary Altwerger
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan, Burak Zeybek, Aranzazu Manzano, Anna Bianchi, Elena Bonazzoli, Stefania Bellone, Natalia Buza, Pei Hui, Salvatore Lopez, Emanuele Perrone, Paola Manara, Luca Zammataro, Gary Altwerger, Chanhee Han, Joan Tymon-Rosario, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, and Alessandro Santin
Submissions from 2019
Robotic Surgery: Research and Reviews is indexed in PubMed, Masoud Azodi and Dawn Hesson
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib, Anna Bianchi, Salvatore Lopez, Gary Altwerger, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Aranzazu Manzano, Paola Manara, Emanuele Perrone, Burak Zeybek, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Justin Y. Newberg, Dean C. Pavlick, Julia Elvin, Garrett M. Frampton, Peter E. Schwartz, and Alessandro D. Santin
PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers, Elena Bonazzoli, Emiliano Cocco, Salvatore Lopez, Stefania Bellone, Luca Zammataro, Anna Bianchi, Aranzazu Manzano, Ghanshyam Yadav, Paola Manara, Emanuele Perrone, Kaitlin Haines, Mariana Espinal, Katherine Dugan, Gulden Menderes, Gary Altwerger, Chanhee Han, Burak Zeybek, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma, Uma Deshmukh, Jonathan Black, Javier Perez-Irizarry, Rachel Passarelli, Karen Levy, Amanda Rostkowski, Pei Hui, Thomas J. Rutherford, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena Ratner, Babak Litkouhi, and Peter E. Schwartz
Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes, Jacqueline Feinberg, Benjamin Albright, Jonathan Black, Lingeng Lu, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, and Peter E. Schwartz
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors, Charles Li, Elena Bonazzoli, Stefania Bellone, Jungmin Choi, Weilai Dong, Gulden Menderes, Gary Altwerger, Chanhee Han, Aranzazu Manzano, Anna Bianchi, Francesca Pettinella, Paola Manara, Salvatore Lopez, Ghanshyam Yadav, Francesco Riccio, Luca Zammataro, Burak Zeybek, Yang Yang-Hartwich, Natalia Buza, Pei Hui, Serena Wong, Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Paola Todeschini, Laura Zanotti, Valentina Zizioli, Franco Odicino, Sergio Pecorelli, Laura Ardighieri, Dan-Arin Silasi, and Babak Litkouhi
Place-specific factors associated with adverse maternal and perinatal outcomes in Southern Mozambique: a retrospective cohort study, Prestige Tatenda Makanga, Charfudin Sacoor, Nadine Schuurman, Tang Lee, Faustino Carlos Vilanculo, Khatia Munguambe, Helena Boene, and Ugochinyere Vivian Ukah
Laparoscopic Ligation of Uterine Vasculature for Fertility-Sparing Management of Postabortal Hemorrhage, Gulden Menderes, Daisy Leon-Martinez, and Masoud Azodi
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial, Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David Scott Miller, Noelle Cloven, Gini F. Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M. Oza, Mihaela Cristea, Jonathan S. Berek, John K. Chan, Bobbie J. Rimel, Daniela E. Matei, Yong Li, Kaiming Sun, Katarina Luptakova, Ursula A. Matulonis, and Bradley J. Monk
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy, Luca Zammataro, Salvatore Lopez, Stefania Bellone, Francesca Pettinella, Elena Bonazzoli, Emanuele Perrone, Siming Zhao, Gulden Menderes, Gary Altwerger, Chanhee Han, Burak Zeybek, Anna Bianchi, Aranzazu Manzano, Paola Manara, Emiliano Cocco, Natalia Buza, Pei Hui, Serena Wong, Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Paola Todeschini, Laura Zanotti, Franco Odicino, Sergio Pecorelli, Carla Donzelli, Laura Ardighieri, Roberto Angioli, Francesco Raspagliesi, Giovanni Scambia, Jungmin Choi, and Weilai Dong
Submissions from 2018
Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer, Benjamin B. Albright, Jonathan D. Black, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Natalia Buza, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, and Peter E. Schwartz
In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers, Gary Altwerger, Elena Bonazzoli, Stefania Bellone, Tomomi Egawa-Takata, Gulden Menderes, Francesca Pettinella, Anna Bianchi, Francesco Riccio, Jacqueline Feinberg, Luca Zammataro, Chanhee Han, Ghanshyam Yadav, Katherine Dugan, Ashley Morneault, Jose F. Ponte, Natalia Buza, Pei Hui, Serena Wong, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer, Gary Altwerger, Esther B. Florsheim, Gulden Menderes, Jonathan Black, Carlton Schwab, Gregory M. Gressel, Wendelin K. Nelson, Nina Carusillo, Terri Passante, Gloria Huang, Babak Litkouhi, Masoud Azodi, Dan-Arin Silasi, Alessandro Santin, Peter E. Schwartz, and Elena S. Ratner
Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer, Elena Bonazzoli, Federica Predolini, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Gulden Menderes, Luca Zammataro, Anna Bianchi, Francesca Pettinella, Francesco Riccio, Chanhee Han, Ghanshyam Yadav, Salvatore Lopez, Aranzazu Manzano, Paola Manara, Natalia Buza, Pei Hui, Serena Wong, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Joseph Schlessinger, and Alessandro D. Santin
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu, Amanda N. Fader, Dana M. Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K. Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M. O'Malley, Floor Backes, Nicole Nevadunsky, Babak Edraki, Dirk Pikaart, William Lowery, Karim S. ElSahwi, Paul Celano, Stefania Bellone, Masoud Azodi, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Peter E. Schwartz, and Alessandro D. Santin
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma, Chanhee Han, Stefania Bellone, Eric R. Siegel, Gary Altwerger, Gulden Menderes, Elena Bonazzoli, Tomomi Egawa-Takata, Francesca Pettinella, Anna Bianchi, Francesco Riccio, Luca Zammataro, Ghanshyam Yadav, Jarrod A. Marto, Marie-France Penet, Douglas A. Levine, Ronny Drapkin, Abhijit Patel, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Natural Orifice-Assisted Laparoscopic Meckel Diverticulectomy Incidentally Found During Para-Aortic Mass Resection, Gulden Menderes, Katherine Dugan, Maximillian J. Klein, and Masoud Azodi
Submissions from 2017
Shoulder Dystocia and Neonatal Resuscitation: An Integrated Obstetrics and Neonatology Simulation Case for Medical Students, Aimee Alphonso, Shefali Pathy, Christie Bruno, Crina Boeras, Beth Emerson, Janice Crabtree, Lindsay Johnston, Vrunda Desai, and Marc Auerbach
Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study, Gary Altwerger, Gregory M. Gressel, Diana P. English, Wendelin K. Nelson, Nina Carusillo, Dan-Arin Silasi, Masoud Azodi, Alessandro Santin, Peter E. Schwartz, and Elena S. Ratner
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro, Stefania Bellone, Eliana Bignotti, Silvia Lonardi, Francesca Ferrari, Floriana Centritto, Alice Masserdotti, Francesca Pettinella, Jonathan Black, Gulden Menderes, Gary Altwerger, Pei Hui, Salvatore Lopez, Christopher de Haydu, Elena Bonazzoli, Federica Predolini, Luca Zammataro, Emiliano Cocco, Federico Ferrari, Antonella Ravaggi, Chiara Romani, Fabio Facchetti, Enrico Sartori, Franco E. Odicino, Dan-Arin Silasi, Babak Litkouhi, Elena Ratner, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Isolated port site recurrence of node-negative clinical stage IB1 cervical adenocarcinoma, Uma Deshmukh, Molly McAdow, Jonathan Black, Pei Hui, and Masoud Azodi
Seasonal variation in geographical access to maternal health services in regions of southern Mozambique, Prestige Tatenda Makanga, Nadine Schuurman, Charfudin Sacoor, Helena Edith Boene, Faustino Vilanculo, Marianne Vidler, Laura Magee, and Peter von Dadelszen
Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression, Gulden Menderes, Elena Bonazzoli, Stefania Bellone, Gary Altwerger, Jonathan D. Black, Katherine Dugan, Francesca Pettinella, Alice Masserdotti, Francesco Riccio, Anna Bianchi, Luca Zammataro, Christopher de Haydu, Natalia Buza, Pei Hui, Serena Wong, Gloria S. Huang, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression, Gulden Menderes, Elena Bonazzoli, Stefania Bellone, Jonathan Black, Gary Altwerger, Alice Masserdotti, Francesca Pettinella, Luca Zammataro, Natalia Buza, Pei Hui, Serena Wong, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo, Gulden Menderes, Elena Bonazzoli, Stefania Bellone, Jonathan D. Black, Salvatore Lopez, Francesca Pettinella, Alice Masserdotti, Luca Zammataro, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression, Gulden Menderes, Elena Bonazzoli, Stefania Bellone, Jonathan Black, Federica Predolini, Francesca Pettinella, Alice Masserdotti, Luca Zammataro, Gary Altwerger, Natalia Buza, Pei Hui, Serena Wong, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Submissions from 2016
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro, Stefania Bellone, Jonathan Black, Diana P. English, Carlton L. Schwab, Salvatore Lopez, Emiliano Cocco, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression, Jonathan Black, Gulden Menderes, Stefania Bellone, Carlton L. Schwab, Elena Bonazzoli, Francesca Ferrari, Federica Predolini, Christopher De Haydu, Emiliano Cocco, Natalia Buza, Pei Hui, Serena Wong, Salvatore Lopez, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Babak Litkouhi, Peter E. Schwartz, Peter Goedings, Patrick H. Beusker, Miranda M. van der Lee, C Marco Timmers, Wim H. Dokter, and Alessandro D. Santin
Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo, Emiliano Cocco, Salvatore Lopez, Jonathan Black, Stefania Bellone, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Carlton L. Schwab, Gulden Menderes, Luca Zammataro, Natalia Buza, Pei Hui, Serena Wong, Siming Zhao, Yalai Bai, David L. Rimm, Elena Ratner, Babak Litkouhi, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Choice of Imaging Studies in Acutely Ill Pregnant Women, Tabassum Firoz, Margaret A. Miller, and Ghada Bourjeily
Community perspectives on the determinants of maternal health in rural southern Mozambique: a qualitative study, Tabassum Firoz, Marianne Vidler, Prestige Tatenda Makanga, Helena Boene, Rogério Chiaú, Esperança Sevene, Laura A. Magee, and Peter von Dadelszen
Chlamydia Peritonitis and Ascites Mimicking Ovarian Cancer, Anar Gojayev, Diana P. English, Matthew Macer, and Masoud Azodi
Obstetric medical care in Canada, Laura A. Magee, Anne-Marie Cote, Geena Joseph, Tabassum Firoz, and Winnie Sia
Corrigendum to "A scoping review of geographic information systems in maternal health" [Int J Gynecol Obstet 134(2016) 13-17], Prestige T. Makanga, Nadine Schuurman, Peter von Dadelszen, and Tabassum Firoz
Incidental injury and repair of obturator nerve during laparoscopic pelvic lymphadenectomy, Gulden Menderes, Nicole Vilardo, Carlton L. Schwab, and Masoud Azodi
Barriers and facilitators to health care seeking behaviours in pregnancy in rural communities of southern Mozambique, Khátia Munguambe, Helena Boene, Marianne Vidler, Cassimo Bique, Diane Sawchuck, Tabassum Firoz, Prestige Tatenda Makanga, and Rahat Qureshi
Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients, John M. Stahl, Henry S. Park, Dan-Arin Silasi, Masoud Azodi, and Shari Damast
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition, Siming Zhao, Stefania Bellone, Salvatore Lopez, Durga Thakral, Carlton Schwab, Diana P. English, Jonathan Black, Emiliano Cocco, Jungmin Choi, Luca Zammataro, Federica Predolini, Elena Bonazzoli, Mark Bi, Natalia Buza, Pei Hui, Serena Wong, Maysa Abu-Khalaf, Antonella Ravaggi, Eliana Bignotti, Elisabetta Bandiera, Chiara Romani, Paola Todeschini, Renata Tassi, Laura Zanotti, Franco Odicino, Sergio Pecorelli, Carla Donzelli, Laura Ardighieri, Fabio Facchetti, Marcella Falchetti, Dan-Arin Silasi, and Elena Ratner
Submissions from 2015
Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors, Maysa M. Abu-Khalaf, Megan A. Baumgart, Scott N. Gettinger, Indukala Doddamane, David P. Tuck, Shihe Hou, Nianhang Chen, Catherine Sullivan, Kimberly Lezon-Geyda, Daniel Zelterman, Christos Hatzis, Hari Deshpande, Michael P. Digiovanna, Masoud Azodi, Peter E. Schwartz, and Lyndsay N. Harris
Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients, Stefania Bellone, Floriana Centritto, Jonathan Black, Carlton Schwab, Diana English, Emiliano Cocco, Salvatore Lopez, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Dan-Arin Silasi, Elena Ratner, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Management of Borderline Ovarian Tumors Based on Patient and Tumor Characteristics, Jonathan D. Black, Gary H. Altwerger, Elena Ratner, Lingeng Lu, Dan-Arin Silasi, Masoud Azodi, Alessandro D. Santin, Peter E. Schwartz, and Thomas J. Rutherford
PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas, Jonathan D. Black, Salvatore Lopez, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Carlton L. Schwab, Diana P. English, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer, Emiliano Cocco, Erik M. Shapiro, Sara Gasparrini, Salvatore Lopez, Carlton L. Schwab, Stefania Bellone, Ileana Bortolomai, Natalia J. Sumi, Elena Bonazzoli, Roberta Nicoletti, Yang Deng, W Mark Saltzman, Caroline J. Zeiss, Floriana Centritto, Jonathan D. Black, Dan-Arin Silasi, Elena Ratner, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, Sergio Pecorelli, and Alessandro D. Santin
High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma, Shari Damast, Susan A. Higgins, Elena Ratner, Maria C. De Leon, Sheida Mani, Dan-Arin Silasi, Masoud Azodi, Alessandro Santin, Thomas Rutherford, and Peter E. Schwartz
Controlled removal of a large uterus within a bowel bag and morcellation in the bowel bag from the vagina, Diana English, Gulden Menderes, and Masoud Azodi
Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo, Diana P. English, Stefania Bellone, Carlton L. Schwab, Dana M. Roque, Salvatore Lopez, Ileana Bortolomai, Emiliano Cocco, Elena Bonazzoli, Sudeshna Chatterjee, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, and Alessandro D. Santin
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro, Francesca Ferrari, Stefania Bellone, Jonathan Black, Carlton L. Schwab, Salvatore Lopez, Emiliano Cocco, Elena Bonazzoli, Federica Predolini, Gulden Menderes, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin
Global obstetric medicine: Collaborating towards global progress in maternal health, Tabassum Firoz, Oier Ateka-Barrutia, Jose Antonio Rojas-Suarez, Chandrika Wijeyaratne, Eliana Castillo, Hennie Lombaard, and Laura A. Magee
Drug-induced fulminant hepatic failure in pregnancy, Tabassum Firoz, Douglas Webber, and Hilary Rowe
Carbon Monoxide Exposure During Pregnancy, Perry Friedman, Xiaoyue M. Guo, Robert J. Stiller, and Steven A. Laifer
Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature, Gregory M. Gressel, Lisbet S. Lundsberg, Gary Altwerger, Tasleem Katchi, Masoud Azodi, Peter E. Schwartz, Elena S. Ratner, and Shari Damast
Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo, Salvatore Lopez, Emiliano Cocco, Jonathan Black, Stefania Bellone, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Carlton L. Schwab, Diana P. English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Corrado Terranova, Roberto Angioli, and Alessandro D. Santin
Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging, Gulden Menderes, Masoud Azodi, Peter Schwartz, and Dan-Arin Silasi